The objective of the fund is to achieve above average and maintainable income but without neglecting capital security and growth. The Manager intends to achieve the objective primarily through the purchase of ordinary shares with an above average yield. There is no restriction on the economic sectors or geographic areas in which the fund may invest.
Name | % Net Assets |
---|---|
GlaxoSmithKline | 5.6% |
Unilever | 5.1% |
British American Tobacco | 5.0% |
Imperial Tobacco | 4.6% |
Royal Dutch Shell 'B' | 4.5% |
Diageo | 3.3% |
Restaurant Group | 3.2% |
Pearson | 3.1% |
William Hill | 3.1% |
Dechra Pharmaceuticals | 3.0% |
Key | % Net Assets |
---|---|
GlaxoSmithKline | 5.6% |
Unilever | 5.1% |
British American Tobacco | 5.0% |
Imperial Tobacco | 4.6% |
Other | 79.7% |
Date | 13-Nov-2024 |
---|---|
NAV | 2,047.22p |
Currency | GBP |
Change | -15.94p |
% | -0.77% |
YTD change | 30.72p |
YTD % | 1.52% |
Fund Inception | 01/02/1971 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research